Cite
HARVARD Citation
Cheng, H. et al. (n.d.). 177 Camrelizumab combined with apatinib for refractory gestational trophoblastic neoplasia: A phase 2, single-arm, prospective Study. International journal of gynecological cancer. pp. A76-A77. [Online].